Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Almazán G[au]:

Search results

Items: 1 to 50 of 111

1.

Distinct age and differentiation-state dependent metabolic profiles of oligodendrocytes under optimal and stress conditions.

Rao VTS, Khan D, Cui QL, Fuh SC, Hossain S, Almazan G, Multhaup G, Healy LM, Kennedy TE, Antel JP.

PLoS One. 2017 Aug 8;12(8):e0182372. doi: 10.1371/journal.pone.0182372. eCollection 2017.

2.

A novel function of TBK1 as a target of Cdon in oligodendrocyte differentiation and myelination.

Wang LC, Kennedy TE, Almazan G.

J Neurochem. 2017 Feb;140(3):451-462. doi: 10.1111/jnc.13882. Epub 2016 Nov 25.

3.

Role of Sonic Hedgehog Signaling in Oligodendrocyte Differentiation.

Wang LC, Almazan G.

Neurochem Res. 2016 Dec;41(12):3289-3299. Epub 2016 Sep 17.

PMID:
27639396
4.

Oligodendrogliopathy in Multiple Sclerosis: Low Glycolytic Metabolic Rate Promotes Oligodendrocyte Survival.

Rone MB, Cui QL, Fang J, Wang LC, Zhang J, Khan D, Bedard M, Almazan G, Ludwin SK, Jones R, Kennedy TE, Antel JP.

J Neurosci. 2016 Apr 27;36(17):4698-707. doi: 10.1523/JNEUROSCI.4077-15.2016.

5.

Quaking Regulates Neurofascin 155 Expression for Myelin and Axoglial Junction Maintenance.

Darbelli L, Vogel G, Almazan G, Richard S.

J Neurosci. 2016 Apr 6;36(14):4106-20. doi: 10.1523/JNEUROSCI.3529-15.2016.

6.

Cdon, a cell surface protein, mediates oligodendrocyte differentiation and myelination.

Wang LC, Almazan G.

Glia. 2016 Jun;64(6):1021-33. doi: 10.1002/glia.22980. Epub 2016 Mar 14.

PMID:
26988125
7.

p38 Mitogen-Activated Protein Kinase Pathway Regulates Genes during Proliferation and Differentiation in Oligodendrocytes.

Haines JD, Fulton DL, Richard S, Almazan G.

PLoS One. 2015 Dec 29;10(12):e0145843. doi: 10.1371/journal.pone.0145843. eCollection 2015.

8.

Purine-crosslinked injectable chitosan sponges promote oligodendrocyte progenitor cells' attachment and differentiation.

Mekhail M, Almazan G, Tabrizian M.

Biomater Sci. 2015 Feb;3(2):279-87. doi: 10.1039/c4bm00215f. Epub 2014 Sep 15.

PMID:
26218118
9.

Properties of human central nervous system neurons in a glia-depleted (isolated) culture system.

Leong SY, Kaplan A, Wang LC, Almazan G, Fournier AE, Antel J.

J Neurosci Methods. 2015 Sep 30;253:142-50. doi: 10.1016/j.jneumeth.2015.06.009. Epub 2015 Jun 18.

PMID:
26093165
10.

Obituary of Theodore L. Sourkes, PhD, FRSC, OC.

Young S, Quik M, Almazan G, Ekker M.

J Psychiatry Neurosci. 2015 May;40(3):214-5. No abstract available.

11.

Role of p38MAPK in S1P receptor-mediated differentiation of human oligodendrocyte progenitors.

Cui QL, Fang J, Kennedy TE, Almazan G, Antel JP.

Glia. 2014 Aug;62(8):1361-75. doi: 10.1002/glia.22688. Epub 2014 May 9.

PMID:
24810969
12.

Agonist-induced down-regulation of AMPA receptors in oligodendrocyte progenitors.

Hossain S, Liu HN, Fragoso G, Almazan G.

Neuropharmacology. 2014 Apr;79:506-14. doi: 10.1016/j.neuropharm.2013.12.020. Epub 2014 Jan 9.

PMID:
24412648
13.

The PTEN inhibitor bisperoxovanadium enhances myelination by amplifying IGF-1 signaling in rat and human oligodendrocyte progenitors.

De Paula ML, Cui QL, Hossain S, Antel J, Almazan G.

Glia. 2014 Jan;62(1):64-77. doi: 10.1002/glia.22584. Epub 2013 Oct 26.

PMID:
24166839
14.

A miniaturized multipurpose platform for rapid, label-free, and simultaneous separation, patterning, and in vitro culture of primary and rare cells.

Didar TF, Bowey K, Almazan G, Tabrizian M.

Adv Healthc Mater. 2014 Feb;3(2):253-60. doi: 10.1002/adhm.201300099. Epub 2013 Aug 15.

PMID:
23949952
15.

Oligodendrocyte progenitor cell susceptibility to injury in multiple sclerosis.

Cui QL, Kuhlmann T, Miron VE, Leong SY, Fang J, Gris P, Kennedy TE, Almazan G, Antel J.

Am J Pathol. 2013 Aug;183(2):516-25. doi: 10.1016/j.ajpath.2013.04.016. Epub 2013 Jun 5.

PMID:
23746653
16.

Rapid, guanosine 5'-diphosphate-induced, gelation of chitosan sponges as novel injectable scaffolds for soft tissue engineering and drug delivery applications.

Mekhail M, Daoud J, Almazan G, Tabrizian M.

Adv Healthc Mater. 2013 Aug;2(8):1126-30. doi: 10.1002/adhm.201200371. Epub 2013 Apr 4.

PMID:
23554366
17.

Mitogen-activated protein kinase p38 regulates Krox-20 to direct Schwann cell differentiation and peripheral myelination.

Hossain S, de la Cruz-Morcillo MA, Sanchez-Prieto R, Almazan G.

Glia. 2012 Jul;60(7):1130-44. doi: 10.1002/glia.22340. Epub 2012 Apr 17.

PMID:
22511272
18.

Oligodendrocyte-protection and remyelination post-spinal cord injuries: a review.

Mekhail M, Almazan G, Tabrizian M.

Prog Neurobiol. 2012 Mar;96(3):322-39. doi: 10.1016/j.pneurobio.2012.01.008. Epub 2012 Jan 28. Review.

PMID:
22307058
19.

Human fetal oligodendrocyte progenitor cells from different gestational stages exhibit substantially different potential to myelinate.

Cui QL, D'Abate L, Fang J, Leong SY, Ludwin S, Kennedy TE, Antel J, Almazan G.

Stem Cells Dev. 2012 Jul 20;21(11):1831-7. doi: 10.1089/scd.2011.0494. Epub 2012 Jan 26.

PMID:
22122665
20.

Type II arginine methyltransferase PRMT5 regulates gene expression of inhibitors of differentiation/DNA binding Id2 and Id4 during glial cell differentiation.

Huang J, Vogel G, Yu Z, Almazan G, Richard S.

J Biol Chem. 2011 Dec 30;286(52):44424-32. doi: 10.1074/jbc.M111.277046. Epub 2011 Oct 31.

21.

The constitutive production of the endocannabinoid 2-arachidonoylglycerol participates in oligodendrocyte differentiation.

Gomez O, Arevalo-Martin A, Garcia-Ovejero D, Ortega-Gutierrez S, Cisneros JA, Almazan G, Sánchez-Rodriguez MA, Molina-Holgado F, Molina-Holgado E.

Glia. 2010 Dec;58(16):1913-27. doi: 10.1002/glia.21061.

PMID:
20878765
22.

The QKI-6 RNA binding protein localizes with the MBP mRNAs in stress granules of glial cells.

Wang Y, Lacroix G, Haines J, Doukhanine E, Almazan G, Richard S.

PLoS One. 2010 Sep 17;5(9). pii: e12824. doi: 10.1371/journal.pone.0012824.

23.

Fas ligand acts as a counter-receptor in Schwann cells and induces the secretion of bioactive nerve growth factor.

Mimouni-Rongy M, White JH, Weinstein DE, Desbarats J, Almazan G.

J Neuroimmunol. 2011 Jan;230(1-2):17-25. doi: 10.1016/j.jneuroim.2010.08.010. Epub 2010 Sep 9.

PMID:
20828835
24.

Response of human oligodendrocyte progenitors to growth factors and axon signals.

Cui QL, Fragoso G, Miron VE, Darlington PJ, Mushynski WE, Antel J, Almazan G.

J Neuropathol Exp Neurol. 2010 Sep;69(9):930-44. doi: 10.1097/NEN.0b013e3181ef3be4.

PMID:
20720504
25.

Regulation of peripheral myelination by Src-like kinases.

Hossain S, Fragoso G, Mushynski WE, Almazan G.

Exp Neurol. 2010 Nov;226(1):47-57. doi: 10.1016/j.expneurol.2010.08.002. Epub 2010 Aug 7.

PMID:
20696161
26.

The QKI-6 RNA binding protein regulates actin-interacting protein-1 mRNA stability during oligodendrocyte differentiation.

Doukhanine E, Gavino C, Haines JD, Almazan G, Richard S.

Mol Biol Cell. 2010 Sep 1;21(17):3029-40. doi: 10.1091/mbc.E10-04-0305. Epub 2010 Jul 14.

27.

Mitogen-activated protein kinase activated protein kinase 2 (MK2) participates in p38 MAPK regulated control of oligodendrocyte differentiation.

Haines JD, Fang J, Mushynski WE, Almazan G.

Glia. 2010 Aug 15;58(11):1384-93. doi: 10.1002/glia.21014.

PMID:
20607863
28.

The insulin-like growth factor-1 axis and its potential as a therapeutic target in central nervous system (CNS) disorders.

Bibollet-Bahena O, Cui QL, Almazan G.

Cent Nerv Syst Agents Med Chem. 2009 Jun;9(2):95-109. Review.

PMID:
20021343
29.

Interaction of Rab31 and OCRL-1 in oligodendrocytes: its role in transport of mannose 6-phosphate receptors.

Rodriguez-Gabin AG, Ortiz E, Demoliner K, Si Q, Almazan G, Larocca JN.

J Neurosci Res. 2010 Feb 15;88(3):589-604. doi: 10.1002/jnr.22236.

30.

Amyloid beta-induced nerve growth factor dysmetabolism in Alzheimer disease.

Bruno MA, Leon WC, Fragoso G, Mushynski WE, Almazan G, Cuello AC.

J Neuropathol Exp Neurol. 2009 Aug;68(8):857-69. doi: 10.1097/NEN.0b013e3181aed9e6.

PMID:
19606067
31.

Cadmium exposure induces mitochondria-dependent apoptosis in oligodendrocytes.

Hossain S, Liu HN, Nguyen M, Shore G, Almazan G.

Neurotoxicology. 2009 Jul;30(4):544-54. doi: 10.1016/j.neuro.2009.06.001. Epub 2009 Jun 11.

PMID:
19523979
32.

The QKI-6 and QKI-7 RNA binding proteins block proliferation and promote Schwann cell myelination.

Larocque D, Fragoso G, Huang J, Mushynski WE, Loignon M, Richard S, Almazan G.

PLoS One. 2009 Jun 11;4(6):e5867. doi: 10.1371/journal.pone.0005867.

33.

IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways.

Bibollet-Bahena O, Almazan G.

J Neurochem. 2009 Jun;109(5):1440-51. doi: 10.1111/j.1471-4159.2009.06071.x. Epub 2009 Mar 28.

34.

Dopamine-induced toxicity is synergistically potentiated by simultaneous HSP-90 and Akt inhibition in oligodendrocyte progenitors.

Hemdan S, Almazan G.

J Neurochem. 2008 May;105(4):1223-34. doi: 10.1111/j.1471-4159.2008.05227.x. Epub 2008 Jan 10.

35.

p38 Mitogen-activated protein kinase regulates myelination.

Haines JD, Fragoso G, Hossain S, Mushynski WE, Almazan G.

J Mol Neurosci. 2008 May;35(1):23-33. Epub 2007 Nov 10. Review.

PMID:
17994198
36.

p38 mitogen-activated protein kinase is required for central nervous system myelination.

Fragoso G, Haines JD, Roberston J, Pedraza L, Mushynski WE, Almazan G.

Glia. 2007 Nov 15;55(15):1531-41.

PMID:
17729284
37.

Deficient peroxide detoxification underlies the susceptibility of oligodendrocyte progenitors to dopamine toxicity.

Hemdan S, Almazan G.

Neuropharmacology. 2007 May;52(6):1385-95. Epub 2007 Feb 20.

PMID:
17400258
38.
39.

Iron contributes to dopamine-induced toxicity in oligodendrocyte progenitors.

Hemdan S, Almazan G.

Neuropathol Appl Neurobiol. 2006 Aug;32(4):428-40.

PMID:
16866988
40.

Human coronavirus OC43 infection induces chronic encephalitis leading to disabilities in BALB/C mice.

Jacomy H, Fragoso G, Almazan G, Mushynski WE, Talbot PJ.

Virology. 2006 Jun 5;349(2):335-46. Epub 2006 Mar 9.

41.
42.
43.

Protection of p27(Kip1) mRNA by quaking RNA binding proteins promotes oligodendrocyte differentiation.

Larocque D, Galarneau A, Liu HN, Scott M, Almazan G, Richard S.

Nat Neurosci. 2005 Jan;8(1):27-33. Epub 2004 Nov 28.

PMID:
15568022
44.

Resistance of human adult oligodendrocytes to AMPA/kainate receptor-mediated glutamate injury.

Wosik K, Ruffini F, Almazan G, Olivier A, Nalbantoglu J, Antel JP.

Brain. 2004 Dec;127(Pt 12):2636-48. Epub 2004 Oct 27.

PMID:
15509624
45.

Developmental differences in HO-induced oligodendrocyte cell death: role of glutathione, mitogen-activated protein kinases and caspase 3.

Fragoso G, Martínez-Bermúdez AK, Liu HN, Khorchid A, Chemtob S, Mushynski WE, Almazan G.

J Neurochem. 2004 Jul;90(2):392-404.

46.

Cytotoxicity of the E(2)-isoprostane 15-E(2t)-IsoP on oligodendrocyte progenitors.

Brault S, Martinez-Bermudez AK, Roberts J 2nd, Cui QL, Fragoso G, Hemdan S, Liu HN, Gobeil F Jr, Quiniou C, Kermorvant-Duchemin E, Lachance C, Almazan G, Varma DR, Chemtob S.

Free Radic Biol Med. 2004 Aug 1;37(3):358-66.

PMID:
15223069
47.

Vesicle transport in oligodendrocytes: probable role of Rab40c protein.

Rodriguez-Gabin AG, Almazan G, Larocca JN.

J Neurosci Res. 2004 Jun 15;76(6):758-70.

PMID:
15160388
48.

Inhibition of p38 mitogen-activated protein kinase interferes with cell shape changes and gene expression associated with Schwann cell myelination.

Fragoso G, Robertson J, Athlan E, Tam E, Almazan G, Mushynski WE.

Exp Neurol. 2003 Sep;183(1):34-46.

PMID:
12957486
49.

Selective neuromicrovascular endothelial cell death by 8-Iso-prostaglandin F2alpha: possible role in ischemic brain injury.

Brault S, Martinez-Bermudez AK, Marrache AM, Gobeil F Jr, Hou X, Beauchamp M, Quiniou C, Almazan G, Lachance C, Roberts J 2nd, Varma DR, Chemtob S.

Stroke. 2003 Mar;34(3):776-82. Epub 2003 Feb 20.

PMID:
12624307
50.

Regulation of muscarinic receptor function in developing oligodendrocytes by agonist exposure.

Molina-Holgado E, Khorchid A, Liu HN, Almazan G.

Br J Pharmacol. 2003 Jan;138(1):47-56.

Supplemental Content

Loading ...
Support Center